Xavier Pharmaceuticals Private Limited - Company Profile

It is a chemicals private limited company based in Karnal, Haryana, India, established in 2013.
2013 Karnal, Haryana, India Struck Off
Last Updated:
Access Report
About Xavier Pharmaceuticals Private Limited

Xavier Pharmaceuticals Private Limited, a struck off private limited company, was established on 13 December 2013 in Karnal, Haryana, India. Engaging in basic chemical within the chemicals sector, it holds CIN: U24100HR2013PTC051304. Registered under ROC Roc Delhi. it is unlisted. It has an authorized capital of ₹0.20 M and a paid-up capital of ₹0.15 M.

Its leadership includes Akash Bangia (Additional Director), Pankaj Arora (Additional Director). Past directors included Jyoti Gaba, Isha, Pankaj Gaba. Its latest AGM occurred on 31 December 2014, with the balance sheet filed on 31 March 2014. It is based at # 513 Bank Colony, Karnal, Haryana, 132001.

Company Details
  • Email
    **********
  • Telephone

    +91-XXXXXXXXXX

  • Website
    **********
  • Social Media
    **********
  • Apps
    **********

Company Details

  • CIN/LLPIN

    U24100HR2013PTC051304

  • Registration Number

    051304

  • Incorporation Date

    13 December 2013

  • Authorized Capital

    ₹0.20 M

  • Paid-Up Capital

    ₹0.15 M

  • ROC Code

    Roc Delhi

  • Listing Status

    Unlisted

  • Company Status

    Struck Off

Key Metrics
  • Authorised Capital ₹ 0.20 M
  • Paid Up Capital ₹ 0.15 M
  • Company Age 12 Year, 2 Months
  • Last Filing with ROC 31 Mar 2014
Company report

Xavier Pharmaceuticals Private Limited

Company Report FY 2025-2026

Comprehensive Company Insights

Explore comprehensive insights into Xavier Pharmaceuticals Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.

Access Report Banner Element
Who are the key members and board of directors at Xavier Pharmaceuticals Private Limited?
Current Directors
Name Designation Appointment Date Status
Akash Bangia Additional Director 04 Apr 2015 Current
Pankaj Arora Additional Director 10 Aug 2016 Current
Past Directors
Name Designation Cessation Status
Pramod Abcsdd Director 04 Apr 2015 Past
Pramod Abcsdd Director 10 Aug 2016 Past
Pramod Abcsdd Additional Director 10 Aug 2016 Past
Pramod Abcsdd Director 10 Aug 2016 Past

Discover detailed profiles of directors and KMP - Unlock leadership insights today!

Financial Performance of Xavier Pharmaceuticals.

Enhance accessibility to Xavier Pharmaceuticals's financial data by unlocking access to both Standalone and Consolidated balance sheets, Profit & Loss Statements, Ratios, Related Party Transactions, and additional relevant information.

Xavier Pharmaceuticals revenue growth over time
Xavier Pharmaceuticals profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors
Emtek
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
Jan, 2021 Amount Post-IPO - Grab Valuation

investors
Hana Financial Group , GGV Capital
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
  • Key Matrics
  • Balance Sheet
  • Profit and Loss
  • Cash Flow
  • Ratios
Metrics
(FY 2023) YOY Growth
(FY 2022) (FY 2021) (FY 2020) (FY 2019)
Total Revenue
********
*******
*******
*******
*******
*******
Revenue from Operations
*******
*******
*******
*******
*******
*******
Total Assets
*******
*******
*******
*******
*******
*******
Profit or Loss
*******
*******
*******
*******
*******
*******
Net Worth
*******
*******
*******
*******
*******
*******
EBITDA
*******
*******
*******
*******
*******
*******

Discover detailed financial data and - Unlock financial today!

What is the Ownership and Shareholding Structure of Xavier Pharmaceuticals?

Unlock access to Xavier Pharmaceuticals's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.

Shareholding Pattern (FY 2024)
shareholding
  • Promoters: 92.83%
  • Public: 4.10%
  • Others: 3.07%
Shareholding Pattern over the Year
FY (2024) FY (2023) FY (2022) FY (2021) FY (2020)
Promoters 92.83 94.62 94.55 94.55 94.55
Public 4.10 3.89 3.95 3.96 3.98
Others 3.07 1.49 1.50 1.49 1.47

Reveal ownership structures and financial performance - Get instant access now!

How Many Employees Work at Xavier Pharmaceuticals?

Unlock and access historical data on people associated with Xavier Pharmaceuticals, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.

Employee Date Number of Employees
2020 78,000
2021 80,500
2022 83,200
2023 86,000
2024 89,500
2025 92,000
Deals i
Graph showing company valuation over time

Gain comprehensive insights into the Deals and Valuation data of Xavier Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Xavier Pharmaceuticals's trajectory.

Rating
Graph displaying rating trends over time

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts
Alert Indicator

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Explore deal ratings and alerts - Get instant access now!

Latest Updates, News, and FAQs on Xavier Pharmaceuticals
Recent Activity within the Organization
  • Director Appointment

    Progress on Pankaj Arora was appointed as a Additional Director was appointed as a Additional Director on 10 Aug 2016 & has been associated with this company since 9 years 6 months . was documented.

  • Director Appointment

    Akash Bangia was appointed as a Additional Director was appointed as a Additional Director on 04 Apr 2015 & has been associated with this company since 10 years 10 months . was recorded as a recent event.

  • Annual General Meeting

    The activity Xavier Pharmaceuticals Private Limited last Annual general meeting of members was held on 31 Dec 2014 as per latest MCA records. was completed.

  • Balance Sheet

    Xavier Pharmaceuticals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2014 with Roc Delhi. was recorded as a recent event.

  • Company Incorporation

    The activity Xavier Pharmaceuticals Private Limited was registered on 13 Dec 2013 with Roc Delhi & aged 12 years 2 months as per MCA records. was completed.

Explore recent activity and updates - View Recent Activity

Frequently Asked Questions
What is the CIN of Xavier Pharmaceuticals Private Limited?

The CIN of Xavier Pharmaceuticals Private Limited is U24100HR2013PTC051304.

Where is Xavier Pharmaceuticals Private Limited headquartered?

Xavier Pharmaceuticals Private Limited is headquartered at # 513 Bank Colony, Karnal, Haryana, 132001.

When was Xavier Pharmaceuticals Private Limited incorporated?

Xavier Pharmaceuticals Private Limited was incorporated on 13 December 2013.

Who are the current directors of Xavier Pharmaceuticals Private Limited?

The current directors of Xavier Pharmaceuticals Private Limited are

What is the primary industry of Xavier Pharmaceuticals Private Limited?

The primary industry of Xavier Pharmaceuticals Private Limited is Chemicals.

Is Xavier Pharmaceuticals Private Limited a listed company?

Xavier Pharmaceuticals Private Limited is unlisted.

What is the capital structure of Xavier Pharmaceuticals Private Limited?

The authorized capital of Xavier Pharmaceuticals Private Limited is ₹0.20 M, and the paid-up capital is ₹0.15 M.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available